Press

“The time to harness the power of AI is now so that we continue to augment Canada’s position on the global AI stage,” said Alexandre Le Bouthillier, founder of Imagia, which made Betakit’s 10 Montreal Startups to Watch list. “By comb

Imagia develops treatment solutions for the pharmaceutical and medical equipment industries. The goal? To make personalized medical care accessible to all. The company uses artificial intelligence to facilitate access care for cancer patients.

Six Montréal-based companies to scale up and expand into new markets.
The Government of Canada is committed to supporting Canada’s high growth-potential businesses to innovate, to increase their productivity and competitiveness, and to access

Imagia teams with pharma, diagnostic, and interventional medical device companies to co-develop healthcare AI products and drive the future of personalized healthcare around the world.

Evidens is Imagia’s collaborative AI ecosystem led by clin

Christie Innomed, a leading Enterprise Imaging provider in Canada and Artificial intelligence (AI) platform provider Imagia, have entered into a collaborative agreement. Our common objective is to mobilize relevant scientific and clinical expert

After extensive software architecture and technology research, the team developed Imagia’s Evidens platform using TensorFlow, Google’s open source machine learning framework, and other key AI tools. “Google’s Cloud MLE allows us to eff

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures…

The Government of Québec awards, through the BioMed Propulsion program, a $ 3 million loan to Imagia to support an artificial intelligence project applied to personalized healthcare.

Researchers at the McGill University Health Center are developing new early diagnostics solutions to deliver better integrated care in personalized medicine…